Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Pioglitazone × Clear all

NCT01838317 2021-03-01

A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

Phase 2 Completed

14 enrolled 8 charts

Gastrointestinal

Pancreatic Neoplasms